- Home
- ENLT vs BHC Comparison
ENLT vs BHC Comparison
Compare ENLT & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLT
- BHC
- Stock Information
- Founded
- ENLT 2008
- BHC N/A
- Country
- ENLT Israel
- BHC Canada
- Employees
- ENLT N/A
- BHC N/A
- Industry
- ENLT
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- ENLT
- BHC Health Care
- Exchange
- ENLT Nasdaq
- BHC Nasdaq
- Market Cap
- ENLT 2.0B
- BHC 1.7B
- IPO Year
- ENLT 2023
- BHC N/A
- Fundamental
- Price
- ENLT $19.50
- BHC $4.53
- Analyst Decision
- ENLT Buy
- BHC Hold
- Analyst Count
- ENLT 3
- BHC 5
- Target Price
- ENLT $19.67
- BHC $7.20
- AVG Volume (30 Days)
- ENLT 28.0K
- BHC 1.5M
- Earning Date
- ENLT 05-06-2025
- BHC 04-30-2025
- Dividend Yield
- ENLT N/A
- BHC N/A
- EPS Growth
- ENLT 90.47
- BHC N/A
- EPS
- ENLT 0.98
- BHC N/A
- Revenue
- ENLT $397,296,000.00
- BHC $9,731,000,000.00
- Revenue This Year
- ENLT $355.90
- BHC $3.71
- Revenue Next Year
- ENLT $42.83
- BHC $5.03
- P/E Ratio
- ENLT $19.18
- BHC N/A
- Revenue Growth
- ENLT 44.42
- BHC 8.53
- 52 Week Low
- ENLT $14.01
- BHC $3.96
- 52 Week High
- ENLT $20.19
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- ENLT 62.94
- BHC 39.91
- Support Level
- ENLT $16.87
- BHC $4.50
- Resistance Level
- ENLT $20.19
- BHC $4.61
- Average True Range (ATR)
- ENLT 0.63
- BHC 0.13
- MACD
- ENLT 0.05
- BHC 0.03
- Stochastic Oscillator
- ENLT 79.26
- BHC 21.30
About ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.